Proteon Therapeutics, Inc. Gains 30.5%
Fri, Jan 17, 2020 at 05:30 PM
Proteon Therapeutics, Inc. (PRTO:NASDAQ) shot up at $0.84, a gain of 30.5%. The stock appeared on our News Catalysts scanner on Thu 09 Jan 20 at 07:00 PM in the 'MERGER' category. From Thu 26 Dec 19, the stock recorded 57.14% Up Days and 93.33% Green Days
About Proteon Therapeutics, Inc. (PRTO:NASDAQ)
Proteon Therapeutics Inc is an late-stage biopharmaceutical company engaged in the development of novel pharmaceuticals to address the needs of patients with renal and vascular disease.
Top 10 Gainers:
- iMedia Brands, Inc. (IMBI:NASDAQ), 42.22%
- CPI Card Group Inc. (PMTS:NASDAQ), 37.7%
- Platinum Group Metals Ltd. (PLG:NYSEMKT), 35.9%
- Titan Pharmaceuticals, Inc. (TTNP:NASDAQ), 33.6%
- Proteon Therapeutics, Inc. (PRTO:NASDAQ), 30.5%
- Seneca Biopharma, Inc. (SNCA:NASDAQ), 28%
- Aptinyx Inc. (APTX:NASDAQ), 27.78%
- Cleveland BioLabs, Inc. (CBLI:NASDAQ), 27.08%
- Kirkland's, Inc. (KIRK:NASDAQ), 25.98%
- Stage Stores, Inc. (SSI:NYSE), 21.99%